Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$1.76 - $2.83 $533 - $857
-303 Reduced 0.4%
75,127 $190,000
Q3 2023

Nov 13, 2023

BUY
$1.99 - $2.45 $5,335 - $6,568
2,681 Added 3.69%
75,430 $180,000
Q2 2023

Aug 04, 2023

SELL
$2.1 - $3.36 $3,326 - $5,322
-1,584 Reduced 2.13%
72,749 $168,000
Q1 2023

May 12, 2023

BUY
$2.13 - $3.6 $7,544 - $12,751
3,542 Added 5.0%
74,333 $189,000
Q4 2022

Feb 10, 2023

SELL
$2.05 - $3.47 $528 - $895
-258 Reduced 0.36%
70,791 $177,000
Q3 2022

Nov 14, 2022

BUY
$0.63 - $5.47 $633 - $5,497
1,005 Added 1.43%
71,049 $206,000
Q2 2022

Aug 12, 2022

BUY
$4.27 - $8.26 $299,087 - $578,563
70,044 New
70,044 $317,000

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.